Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
did you read all posts? and see map -- they are covered.
oops wrong board please delete.
Thanks for the clarification. Lets hope for the best.
going back a few years I recall a discussion I had with Lakey. He implied they had enough parts to make 2 autoclaves. Would assume many of the common parts have been sold but maybe not. If this guy is really as sharp as he comes across we might see a sale or two.
The company can be saved (as well as everyone's shares), however, regaining compliance, etc. must happen in short order.
Otherwise, that's it.
Thanks,
Are our shares worthless? Could they save it or do they need to come back under different company name which would make our investment zero?
Got a few PM's asking for clarification. Essentially, if you have the resources to make a speculative capital investment, with the immediate goals of MCLN being SEC compliant, trading, and moving forward in a positive new direction - call Mr. Allen to participate.
MCLN update: Private offering for accredited investors. Interested parties may contact Phil Allen, VP Corporate Finance (tel: 303.875.1044). He is handling the corporate finance and investment side getting ready to restructure and effect a new merger.
You can kiss MCLN goodbye. Its been revoked.
I wonder why the SEC only gave them 45 days? MedClean was supposed to have 90days.
now it's really over
I noticed that. 134M shares for CEO, 57M for the VP/Treasurer. Even past management gets some shares. Definitely incentive to grow the biz. Just need to get the financials done and get in good graces of the SEC again. Quickly.
The new CEO is getting all the shares from the past Ceo's so he'll have a huge incentive to grow this company. Let's hope he can get it going!!!
This is the first trade i've seen since the SEC has stepped in. A whole $5.00 bucks, are you kidding me. Who would bother? makes no sense to me.
I'd be interested if you got a reply.
One tiny trade goes thru each day since late last week. Odd.
Found the new CEO on LinkedIn. Wished him well and asked to release a plan going forward when he can.
200 shares trade and the pps stay even????????
We're still hanging on by the skin of our teeth, I guess you can say.
Wonder what the cost to file the financials is? Hope this new CEO can get the ball rolling and get this company on the right track.
8K released. New management. Not over yet.
http://biz.yahoo.com/e/150401/mcln8-k.html
"The Company has not responded to the Commission nor OTC Markets, however, management intends to use its best efforts to bring its financial statements current and file them as soon as practicable."
MCLN SEC Admin Law Judge Initial Decision to revoke registration on DEFAULT:
http://www.sec.gov/alj/aljdec/2015/id761ce.pdf
The website was taken down. The default placeholder webpage is ad driven, usually by the domain registrar.
Management has moved on and company done.
The months long rumor is whether another party has taken on the shell, will become SEC compliant and move it forward.
The next SEC announcement should answer that. They had to 'show cause' by 3/27 (last friday) or else.
We will all know shortly.
Check out the re-vamped Medclean website
http://www.medcleantechnologies.com/
To quote ttxxhorns: Something is coming!
This company is now traded on the grey sheets.
See a couple of posts back from Renee
My open order was cancelled, was MCLN delisted?
According to the CEO, we are supposed to get an update this week. They have until 3/27 to make a statement or "show cause" (according to the SEC), so it's now or never.
Now trading on the grey market
http://www.extraordinaryinvestor.com/grey-sheets.html
MCLN: SEC Admin Law Judge Order: ***Failure to respond!!
http://www.sec.gov/alj/aljorders/2015/ap-2432.pdf
Thanks, at least something.
Got a reply... Expect to see something either next week or the week after. Looking forward to hearing the path forward. Won't be easy, but I prefer it over nothing.
No recent statements or news on the SEC website since Feb 25 suspension. Not a peep as expected. Zilch.
As expected we hear nothing. Is something, at least alittle something going on?
Thanks Pack. I emailed John on monday and when I asked him if it was game over, he didn't say yes. I got a maybe. He was waiting to hear that day if it was or wasn't. I know he can't say anything that's not public, but it was cryptically hopeful. I assumed a forgone conclusion it was adios.
To hear it's still not 100% certain even now is surprising. Guess the SEC is still listening & MCLN is still trying. If this long rumored deal is happening, maybe they can get financials filed pronto. Still leaves a lot in limbo, but a start.
I don't expect a PR. I want to read the required answer to the SEC (if they file one), which is due 10 days from the SEC notice. That'll tell us a lot.
Not 100% certainty, but pretty darn close to it. My question, for some ray of hope with this outfit, will John put out a pr on what he gives the SEC? Highly doubtful, my guess. Almost a year ago now I contacted my local SEC office concerning companies that put themselves in the " no information" mode. I had a real good conversation with this individual and he said it was because of the money involved with staying current on their filings. That made sense to me. We didn't get into the costs but considering this company couldn't seem to generate any sales it seemed appropriate. Fast forward to today, i'm sure no to little sales, merger, partnership, highly doubtful. Whats left?
Thanks pack. I thought you might say that.
I'll try and be at my computer after market close for one hour.
Any word on MCLN?
Thanks for your reply. It has been for some time.
Hows that crystal ball?
Either way, you will win.
Compared to the market value on your statement is today.
If they don't file an answer, when this starts trading again on 3/11, there will be a flood to the exits and down she goes. Not enough lifeboats either.
Here's to hoping they manage to reply to the SEC.
MCLN's website has been down for a few days due to bandwidth limitation exceeded. Got some anxious & peeved investors.
Two possiblities.
Either way, we are going to make more gains than what we have now.
We will all know something very shortly. They have 7 more days to file an answer to the SEC. If they do, we may have a shred of hope. If they don't, that's it.
There is no excuse that MCLN has not filed even unaudited results to stay current and avoid this. Wouldn't take much time, money or effort.
Somebody knows something!
And soon we will too!
Well, at least now we will start to get some answers. MCLN is required to file a response to this within 10 days. Temporary suspension of trading ends 3/10/15.
MCLN SEC Suspension for Financials delinquencies:
http://www.sec.gov/litigation/suspensions/2015/34-74367.pdf
Order:
http://www.sec.gov/litigation/suspensions/2015/34-74367-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2015/34-74366.pdf
Are you going to every board on that list. I just read your same comments on another board.
Those of us who have followed MCLN know this. Tell us something we don't know.
MCLN is severely delinquent in filing their Financials and corporate filing obligations to the SEC. On Feb. 20, 2015 the SEC suspended 8 stocks from the Delinquent SEC Filers list, and it is likely that more delinquent Filers will be suspended.
Since Jan 1st, 2010 the SEC has suspended over 1290 stocks for Financials delinquencies. All of those Suspended stocks had their stock registrations revoked.
Shareholders should contact the company and pressure the Mgmt to file their delinquent Financials because ALL shareholders would be wiped out IF the SEC suspends the stock.
MCLN is on the list of delinquent filers:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110680509
Well....that makes the OS 24M ......fwtfw.......et z
Yes they did in April 2013.
Since then they had been trying for RM. And they did not dilute any share.
They ever do that 1-100 RS they filed for in 2013?......et z
Followers
|
222
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
35151
|
Created
|
11/04/09
|
Type
|
Free
|
Moderators |
http://www.medcleantechnologies.com/
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut.
(Click on link below to view a must see video.)
http://www.youtube.com/watch?v=GTpuKnWo2QI
http://www.reuters.com/article/pressRelease/idUS119193+26-Mar-2009+PRN20090326
MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
Thu Mar 26, 2009 8:00am EDT
MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals
MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue
cycle solutions that help control cost, improve margins and cash flow,
increase regulatory compliance, and optimize operational efficiency. MedAssets
serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers.
http://finance.yahoo.com/q/pr?s=MDAS
(MedAssets Trades on the NASDAQ as MDAS at over $20.00+ per share.)
MedClean Technologies, Inc. Approved in New Jersey
http://www.reuters.com/article/pressRelease/idUS141127%2B12-May-2009%2BPRN20090512
Garden State Hospitals Can Now Enjoy MedClean Guaranteed Saving Program
Approval Follows Joint Authorization Process by NJ Department of Environmental
Protection and NJ Department of Health and Senior Services
http://www.state.nj.us/dep/dshw/rrtp/aamwdt.04.htm
Part 1
Part 2
Efficacy
MedClean Technologies sets the standard for efficacy testing and validation through an ongoing commitment that has resulted in the most extensive body of work in the industry. The MedClean System meets and exceeds the most demanding standards throughout all 50 states. Our work in this area has yielded a protocol that includes significant proprietary intellectual property and is the subject of a United States patent. All MedClean efficacy testing and protocol development is conducted using actual RMW from healthcare institutions to mirror real world operations.
MedClean Technologies is committed to ongoing research and development in this area and to close collaboration with industry experts to provide continuous enhancement of its Best Practices.
http://www.medcleantechnologies.com/process-overview
http://www.medcleantechnologies.com/container-and-mobile-solutions
http://www.medcleantechnologies.com/fixed-and-custom-solutions
System Components
http://www.medcleantechnologies.com/system-components
Medcleantechnologies, Inc. Partnerships: http://www.medcleantechnologies.com/partners style="font-size: medium;">
http://sterilizers360.com/sterilizers/aduramed-patent-application-becomes-medclean.html
Per Yahoo & SEC Filings:
http://knobias.10kwizard.com/filing.php?param=&ipage=6972085&DSEQ=1&SEQ=&SQDESC=SECTION_BODY&exp=
http://finance.yahoo.com/q/ks?s=MCLN.OB
Outstanding Shares (OS) = 809,743,450 as of Dec 2010
Restricted Shares = 293.43
Float = 588.34M
Authorized Shares (AS) = 3.5B
Management Team
http://www.medcleantechnologies.com/management-team
Chairman of the Board of Directors
Mr. Bendis was appointed as Chairman of the Board of the Company effective March 31, 2011. Mr. Bendis has been President of Transfer Technology Consultants during the past 20 years specializing in transferring emerging life science product concepts from design to commercialization in both domestic and international markets. He was President and CEO of Clinical Analysis Corp., which has developed a hand-held diagnostic system for patient point-of-care testing. He was Managing Partner in the Crystal Corridor Group which worked with Kent State University's Liquid Crystal Institute in facilitating liquid crystal technology. He was Executive Vice President of American BioMedica Corp, which develops, manufacturers and markets immunoassay diagnostic test kits for the workplace, correctional and clinical markets. He was President and Co-founder of Emerging Technology Systems which is a research and development company consisting of engineers specializing in developing new medical devices. His prior management positions had been with XANAR Laser Corp, a division of Johnson & Johnson as the National Sales Manager and Sales and Marketing Manager for the IVAC Corp., a division of Eli Lilly and had sales and management experience with XEROX. He was also a member of the Edison BioTechnology Center Advisory Council for the State of Ohio and presently serves on the Board of Directors of several privately and publicly held companies.
David J. Laky
President and Chief Executive Officer
Mr. Laky was appointed to the positions of President and Chief Executive Officer of the Company effective November 9, 2009. Prior to such appointment Mr. Laky was the Company's Senior Vice President of Client Services and Technology since September 2008. Mr. Laky joined the Company from eResearch Technology, Inc. where from 2005 to 2008 he was General Manager & Vice President of eClinical Group. He served eRT as VP of Professional Services from 1999 to 2005.
Cheryl K. Sadowski
Chief Financial Officer
Ms. Sadowski was appointed to the positions of Chief Financial Officer of the Company effective August 4, 2009. Prior to such appointment Ms. Sadowski was the Company's Vice-President and Controller since October 2008. From February 1994 until October 2008 she held several positions at eResearchTechnology, Inc. in Bridgewater, New Jersey, including Vice President, Business Management and Senior Director, Business Management, where she was responsible for budgeting, forecasting, financial systems and analysis for the Professional Services, Project Management, Customer Care, Research & Development, IT and Cardiac Safety Divisions. She also handled the facilities management and administration for the Bridgewater office.
.
Senior Vice President of Sales/Business Development
Mr. Accardi was named Senior Vice President of Sales/Business Development in September, 2008. Prior, he was with Oracle Corporation/Siebel Systems, where he was responsible for a $40 million line of business and led sales efforts for the financial services and insurance markets in the southeast region and, earlier, served as Senior Director of Siebel's North American Reseller Network. Previously, he served as Vice President of Worldwide Sales for Rasterex, a global provider of software and services extending the value of Auto-Cad solutions. At Rasterex, Mr. Accardi drove $15 million in first year revenue and reversed an operating loss to a profit during the same period. Previously, he served in executive management capacities at systems integrator Gary Brown & Associates and applications provider Computron Software, Inc., Ross Systems and WANG Laboratories.
MCLN Contact Info
http://finance.yahoo.com/q/pr?s=MCLN.OB
MedClean Technologies, Inc
3 Trowbridge Drive
Bethel, CT 06801
Phone: 203-798-1080
Fax: 203-798-0147
Web Site: http://www.medcleantechnologies.com/
Daily View
Weekly View
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |